Explore our comprehensive coverage of biomarkers, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The simultaneous FDA fast-tracking of oral metabolic triple-agonists and the validation of plasma p-tau217 biomarkers marks a definitive pivot from re...
Read Full Story →
Healthcare PolicyA landmark 2026 Boston University study reveals that the NFL Concussion Settlement's standardized te...
Medical ResearchRecent 2026 clinical data reveals a bidirectional acceleration between sports-related concussion bio...
Medical ResearchUniversity of Miami researchers identified an abnormal UNC13A RNA signature, tied to TDP-43 dysfunct...
Medical ResearchThe FDA's August 13 accelerated approval of iberdomide (Zenbexus) with daratumumab and dexamethasone...
Medical ResearchResearchers from the NIH and Mayo Clinic have identified a novel panel of blood biomarkers capable ...
